St. John's Wort 300 mg

St. John's Wort 300 mg

Format:Capsule Quantity: 60 Capsule(s) · 60 servings
Goals
$7.22 $0.12 per serving

Product analysis

61 out of 100

St. John's Wort 300 mg is a mood supplement whose evidence comes from specific extracts used in people with diagnosed depression. It can weaken many medicines and interact with medicines that affect serotonin, making medication use a key suitability concern.

AI assessment of the formula, label and price. How scoring works

Nutrient Quality40

Hypericin is identified, but that alone does not establish the quality of the extract. A clear absorption advantage cannot be confirmed.

Ingredient Transparency100

The serving amount is stated, allowing amount comparisons. Hypericin standardization provides another way to distinguish extracts.

Value For Money40

The value of the extract remains uncertain. A stated amount and hypericin detail do not establish a price advantage.

Customer Satisfaction86

Customer ratings are generally positive. Feedback from 5,744 ratings gives a broad picture of satisfaction.

Product Focus55

The single-herb formula focuses on mood support, with evidence tied to particular extracts and clinical settings. One 300 mg serving does not by itself match the 900 mg daily regimen behind those findings.

Format
Capsule
Container
60 Capsule(s)
Per serving
$0.12
Customer rating
4.6 · 5,744 ratings
Report analysis

Goals

Mood Support
Impact
High effect
B- Ingredient FitF PathwaysB+ EvidenceA+ Formulation Logic
Study evidence
Stress Relief
Impact
Lower effect
A+ Ingredient FitF PathwaysD- EvidenceA+ Formulation Logic
Study evidence

Ingredients

IngredientAmount per servingScore
St. John's Wort Flowering Tops Extract (Hypericin)
300 mg 100
Gluten Free Adults 18–50 Dairy Free No Allergies
Report overview
A+ Composition And Label Disclosure
The serving lists 300 mg of St. John's Wort Flowering Tops Extract; the available price covers the whole product, not the herb alone. A specific warning is recorded, but its wording is unavailable.
How this ingredient is rated

Composition and Label Disclosure

Composition was not assessed separately.

Composition and Label Disclosure100

A specific warning is recorded, but its wording is unavailable.
Explicit Label Detail
A specific warning is recorded, but its wording is unavailable.

Commercial Price and Usability

Value was not assessed for this ingredient.
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. St John's wort for major depression.
    Linde K; Berner MM; Kriston L · The Cochrane database of systematic reviews · 2009
    Systematic review5,489 participants29 studies pooledMood Support forSt. John's Wort
  2. Efficacy of St. John's wort extract WS 5570 in major depression: a double-blind, placebo-controlled trial.
    Lecrubier Y; Clerc G; Didi R; Kieser M · The American journal of psychiatry · 2002
    Randomized trial375 participantsMood Support forSt. John's Wort
  3. A systematic review and meta-analysis of Hypericum perforatum in depression: a comprehensive clinical review.
    Whiskey E; Werneke U; Taylor D · International clinical psychopharmacology · 2002
    Meta-analysis22 studies pooledMood Support forSt. John's Wort
  4. Efficacy and tolerability of hypericum extract WS 5572 versus placebo in mildly to moderately depressed patients. A randomized double-blind multicenter clinical trial.
    Kalb R; Trautmann-Sponsel RD; Kieser M · Pharmacopsychiatry · 2001
    Randomized trial72 participantsMood Support forSt. John's Wort
  5. Complementary therapies for clinical depression: an overview of systematic reviews.
    Haller H; Anheyer D; Cramer H; Dobos G · BMJ open · 2020
    Systematic review26 studies pooledMood Support forSt. John's Wort
  6. Comparison of St John's wort and imipramine for treating depression: randomised controlled trial.
    Woelk H · BMJ (Clinical research ed.) · 2000
    Randomized trial324 participantsStress Relief forSt. John's Wort
  7. Differential therapy of mild to moderate depressive episodes (ICD-10 F 32.0; F 32.1) with St. John's wort.
    Friede M; Henneicke von Zepelin HH; Freudenstein J · Pharmacopsychiatry · 2002
    Randomized trial240 participantsStress Relief forSt. John's Wort
  8. Kava and St. John's Wort: current evidence for use in mood and anxiety disorders.
    Sarris J; Kavanagh DJ · Journal of alternative and complementary medicine (New York, N.Y.) · 2009
    Systematic reviewStress Relief forSt. John's Wort
  9. Do early changes in the HAM-D-17 anxiety/somatization factor items affect the treatment outcome among depressed outpatients? Comparison of two controlled trials of St John's wort (Hypericum perforatum) versus a SSRI.
    Bitran S; Farabaugh AH; Ameral VE; LaRocca RA; Clain AJ; Fava M; Mischoulon D · International clinical psychopharmacology · 2012
    Other475 participantsStress Relief forSt. John's Wort
  10. Nutritional and herbal supplements for anxiety and anxiety-related disorders: systematic review.
    Lakhan SE; Vieira KF · Nutrition journal · 2011
    Systematic review2,619 participants24 studies pooledStress Relief forSt. John's Wort